In addition, caspase-3-dependent apoptotic pathways were activated by these treatments, especially in the Fe2O3@TA-Pt NPs plus RT group (Additional file 1: Fig. S16), indicating that our nanoplatforms could also activate the caspase-dependent apoptosis paths for tumor therapy. Here, CASP3 is linked to neoplasm.